A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Oncology Institute, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 140,100 shares of TOI stock, worth $68,649. This represents 0.0% of its overall portfolio holdings.

Number of Shares
140,100
Previous 89,300 56.89%
Holding current value
$68,649
Previous $182,000 21.43%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$1.36 - $2.3 $69,088 - $116,839
50,800 Added 56.89%
140,100 $221,000
Q4 2023

Feb 13, 2024

BUY
$1.14 - $2.55 $19,380 - $43,350
17,000 Added 23.51%
89,300 $182,000
Q3 2023

Nov 14, 2023

SELL
$0.5 - $1.66 $1,671 - $5,547
-3,342 Reduced 4.42%
72,300 $101,000
Q2 2023

Aug 11, 2023

SELL
$0.35 - $0.72 $19,900 - $40,937
-56,858 Reduced 42.91%
75,642 $42,000
Q1 2023

May 12, 2023

BUY
$0.48 - $1.7 $63,600 - $225,250
132,500 New
132,500 $90,000

Others Institutions Holding TOI

About Oncology Institute, Inc.


  • Ticker TOI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 73,495,504
  • Market Cap $36M
  • Description
  • The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical tr...
More about TOI
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.